Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cytokeratin 20-positive hepatocellular carcinoma.

Fanni D, Nemolato S, Ganga R, Senes G, Gerosa C, Van Eyken P, Geboes K, Faa G.

Eur J Histochem. 2009 Dec 29;53(4):e32. doi: 10.4081/ejh.2009.e32.

2.

Cytokeratin 20-positive hepatocellular carcinoma.

Fanni D, Nemolato S, Ganga R, Senes G, Gerosa C, Van Eyken P, Geboes K, Faa G.

Eur J Histochem. 2009 Dec 1;53(4):269-73.

PMID:
20007098
3.
4.

Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.

Ryu HS, Lee K, Shin E, Kim SH, Jing J, Jung HY, Lee H, Jang JJ.

Tumori. 2012 Jul-Aug;98(4):478-84. doi: 10.1700/1146.12643.

PMID:
23052165
5.
6.

The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.

Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, Keogh A, Stroka D, Zimmermann A, Stickel F.

J Hepatol. 2010 Mar;52(3):362-9. doi: 10.1016/j.jhep.2009.12.006. Epub 2010 Jan 13.

PMID:
20137822
7.

Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.

Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L.

Am J Surg Pathol. 2003 Oct;27(10):1302-12.

PMID:
14508391
8.
11.
12.

The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.

Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M.

Mod Pathol. 1996 Sep;9(9):901-9.

PMID:
8878022
13.

Merkel cell carcinoma with an unusual immunohistochemical profile.

Pilloni L, Manieli C, Senes G, Ribuffo D, Faa G.

Eur J Histochem. 2009 Dec 29;53(4):e33. doi: 10.4081/ejh.2009.e33.

14.
15.

Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.

Lau SK, Prakash S, Geller SA, Alsabeh R.

Hum Pathol. 2002 Dec;33(12):1175-81.

PMID:
12514785
16.

[Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].

Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H.

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):702-5. Chinese.

PMID:
19173916
17.

Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.

Shafizadeh N, Ferrell LD, Kakar S.

Mod Pathol. 2008 Aug;21(8):1011-8. doi: 10.1038/modpathol.2008.85. Epub 2008 Jun 6.

18.
19.

Supplemental Content

Support Center